Escriber, Kurt Asher F.
HRN: 23-58-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 1GM (VIAL)
08/22/2023
08/29/2023
IVTT
210mg
Q6
TC Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes